[Hepatic toxicity in HER-2(+) breast cancer patient under treatment with capecitabine and lapatinib]

Farm Hosp. 2016 Mar 1;40(2):134-6. doi: 10.7399/fh.2016.40.2.9360.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / complications*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / genetics*
  • Capecitabine / adverse effects*
  • Capecitabine / therapeutic use
  • Carcinoma, Ductal, Breast / complications*
  • Carcinoma, Ductal, Breast / drug therapy
  • Carcinoma, Ductal, Breast / genetics*
  • Chemical and Drug Induced Liver Injury / etiology*
  • Female
  • Humans
  • Lapatinib
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use
  • Receptor, ErbB-2 / genetics*

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Quinazolines
  • Lapatinib
  • Capecitabine
  • ERBB2 protein, human
  • Receptor, ErbB-2